ArticleBreast cancer research : BCR2025

Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells.

Ashley V Ward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.